CT-155 (Boehringer Ingelheim and Click Therapeutics), an investigational prescription digital therapeutic, was both safe and effective in reducing negative symptoms of schizophrenia in a new phase 3 ...

Russia is facing a shortage of drugs which are used for the treatment of schizophrenia, psychosis, bipolar disorder, and ...

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

Doxycycline, a broad-spectrum antibiotic commonly used to treat infections and acne, may help reduce the risk for schizophrenia in high-risk adolescents, new research suggests. A Finnish registry ...

Schizophrenia is a severe and often highly debilitating psychiatric disorder characterized by distorted emotions, thinking patterns and altered perceptions of reality, as well as mental impairments.

A large genetic study reveals shared genetic patterns linking schizophrenia with bone health, highlighting the need for ...